Simplex Trading’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.2M Sell
48,800
-7,700
-14% -$2.75M 0.01% 483
2025
Q4
$18.5M Sell
56,500
-65,400
-54% -$20.7M 0.01% 581
2025
Q3
$34.4M Buy
121,900
+4,000
+3% +$1.16M 0.02% 452
2025
Q2
$32.9M Sell
117,900
-76,600
-39% -$21.7M 0.02% 397
2025
Q1
$60.6M Buy
194,500
+38,000
+24% +$11.2M 0.04% 228
2024
Q4
$40.8M Sell
156,500
-80,300
-34% -$23.8M 0.02% 369
2024
Q3
$64.5M Buy
236,800
+8,100
+4% +$2.65M 0.04% 247
2024
Q2
$71.5M Sell
228,700
-29,600
-11% -$8.7M 0.04% 226
2024
Q1
$73.4M Sell
258,300
-11,800
-4% -$3.45M 0.04% 243
2023
Q4
$77.8M Buy
270,100
+69,900
+35% +$19M 0.05% 234
2023
Q3
$53.8M Buy
200,200
+35,500
+22% +$8.86M 0.04% 273
2023
Q2
$36.6M Buy
164,700
+50,500
+44% +$11.7M 0.03% 344
2023
Q1
$27.6M Sell
114,200
-106,400
-48% -$26.1M 0.02% 457
2022
Q4
$57.9M Buy
220,600
+73,600
+50% +$19.7M 0.06% 235
2022
Q3
$33.1M Sell
147,000
-12,900
-8% -$3.13M 0.04% 351
2022
Q2
$38.9M Buy
159,900
+51,200
+47% +$12.5M 0.04% 304
2022
Q1
$26.3M Buy
108,700
+14,400
+15% +$3.31M 0.02% 445
2021
Q4
$21.2M Sell
94,300
-36,400
-28% -$7.68M 0.02% 492
2021
Q3
$32.3M Buy
130,700
+1,800
+1% +$414K 0.03% 330
2021
Q2
$31.4M Buy
+128,900
New +$31.7M 0.03% 326
2021
Q1
Sell
-1,351
Closed -$31.1M 8707
2020
Q4
$31.1M Buy
1,351
+286
+27% +$65.9K 0.04% 256
2020
Q3
$27.1M Buy
1,065
+30
+3% +$7.43K 0.04% 272
2020
Q2
$24.4M Sell
1,035
-799
-44% -$182K 0.04% 258
2020
Q1
$37.2M Sell
1,834
-362
-16% -$79.1K 0.07% 154
2019
Q4
$52.9M Buy
2,196
+152
+7% +$33.5K 0.12% 100
2019
Q3
$39.6M Buy
2,044
+701
+52% +$135K 0.11% 116
2019
Q2
$24.7M Sell
1,343
-1,846
-58% -$331K 0.07% 191
2019
Q1
$60.6M Buy
3,189
+976
+44% +$186K 0.17% 74
2018
Q4
$43.1M Buy
2,213
+531
+32% +$104K 0.13% 91
2018
Q3
$34.9M Buy
1,682
+536
+47% +$106K 0.11% 120
2018
Q2
$21.2M Sell
1,146
-168
-13% -$29.7K 0.08% 171
2018
Q1
$1.27M Sell
1,314
-1,119
-46% -$205K 0.06% 309
2017
Q4
$1.05M Sell
2,433
-12
-0.5% -$2.12K 0.05% 378
2017
Q3
$386K Sell
2,445
-830
-25% -$147K 0.02% 803
2017
Q2
$918K Sell
3,275
-1,046
-24% -$170K 0.04% 397
2017
Q1
$990K Buy
4,321
+1,910
+79% +$317K 0.04% 389
2016
Q4
$1.23M Sell
2,411
-540
-18% -$81.3K 0.07% 234
2016
Q3
$730K Sell
2,951
-143
-5% -$24.2K 0.05% 357
2016
Q2
$876K Buy
3,094
+764
+33% +$119K 0.06% 318
2016
Q1
$1.31M Buy
2,330
+696
+43% +$103K 0.1% 173
2015
Q4
$428K Sell
1,634
-72
-4% -$11.3K 0.03% 491
2015
Q3
$2.1M Buy
1,706
+621
+57% +$97.9K 0.15% 122
2015
Q2
$378K Buy
1,085
+557
+105% +$89.2K 0.03% 485
2015
Q1
$187K Buy
+528
New +$83.2K 0.02% 752

Other funds holding AMGN

Simplex Trading's AMGN Position: Q4 2025 in Review

Simplex Trading sold out of Amgen (AMGN) in Q4 2025, closing a stake of 4,602 shares — an estimated $1.46M sold.

Simplex Trading first reported a position in AMGN in Q4 2014 and held it in 22 quarters. The position peaked at $32.3M in Q2 2017. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Simplex Trading reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 4,602 Amgen shares in Q4 2025, an estimated $1.46M.
  • Simplex Trading first reported a position in Amgen in Q4 2014 and held it in 22 quarters.
  • Simplex Trading's Amgen position peaked at $32.3M in Q2 2017.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.